An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Published 2017 View Full Article

Authors

Keywords

Non-muscle invasive bladder cancer, Oncolytic adenovirus, Intravesical therapy, BCG unresponsive

Journal

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2017-07-27

DOI

10.1016/j.urolonc.2017.07.005

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started